Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Warrants--ease, This may help--ads

Dec 20, 2006 04:24PM

Dec 20, 2006 05:13PM

Dec 21, 2006 02:21AM

Dec 21, 2006 04:17AM

Dec 21, 2006 05:02AM

Dec 22, 2006 04:34AM

Dec 22, 2006 05:12AM

Dec 22, 2006 05:32AM

Dec 22, 2006 05:53AM

Dec 22, 2006 06:12AM

Dec 22, 2006 06:18AM

Dec 22, 2006 06:31AM

PRINCIPAL SHAREHOLDERS

The following table sets forth, as of February 28, 2006, the stock ownership of each officer and director of the Company, of all officers and directors of the Company as a group, and of each person known by the Company to be a beneficial owner of 5% or more of its Common Stock. The number of shares of Common Stock outstanding as of February 28, 2006, was 349,926,038. Except as otherwise noted, each person listed below is the sole beneficial owner of the shares and has sole investment and voting power over such shares. No person listed below has any option, warrant or other right to acquire additional securities of the Company, except as otherwise noted. Other than Mr. Giffhorn, Lincoln Ventures, LLC and Swartz Private Equity, LLC, each individuals address is Carlsbad Corporate Plaza, 6183 Paseo Del Norte, Suite 180, Carlsbad, California 92011. Mr. Giffhorns address is 10875 Kemah Lane, San Diego, California 92131. The address of each of Lincoln Ventures, LLC and Swartz Private Equity, LLC is 1125 Sanctuary Parkway, Suite 275, Alpharetta, GA 30004.

                                                           Amount & Nature
                                                            of Beneficial
Name                                                          Ownership         Percent of Class
Gloria Felcyn, CPA                                                 744,700 (1)                  *
Helmut Falk, Jr.                                                 2,918,231 (2)                  *
Lowell W. Giffhorn                                                 877,948 (3)                  *
Carlton M. Johnson, Jr.                                            975,000 (4)                  *
David H. Pohl                                                      875,000 (5)                  *
Thomas J. Sweeney                                                        0                      *
James Turley                                                       200,000 (4)                  *
Lincoln Ventures, LLC                                           35,543,977 (6)               9.99 %
Swartz Private Equity, LLC                                      35,543,977 (6)               9.99 %
All directors & officers as a group (7 persons)
* Less than 1%                                                   6,590,879 (7)               1.87 %

(1) Includes 450,000 shares issuable upon the exercise of outstanding stock options exercisable within 60 days of February 28, 2006.
(2) Includes 490,000 shares issuable upon the exercise of outstanding stock options exercisable within 60 days of February 28, 2006.
(3) Includes 820,000 shares issuable upon the exercise of outstanding stock options exercisable within 60 days of February 28, 2006.
(4) Represents shares issuable upon the exercise of outstanding stock options exercisable within 60 days of February 28, 2006.
(5) Includes 725,000 shares issuable upon the exercise of outstanding stock options exercisable within 60 days of February 28, 2006.
(6) Lincoln Ventures, LLC (Lincoln) and Swartz Private Equity, LLC (SPE and together with Lincoln, the Reporting Person) have shared voting power and shared dispositive power as to these shares. This number also includes 5,869,538 shares issuable upon exercise of outstanding warrants exercisable within 60 days of February 28, 2006. Lincoln and SPE each hold warrants to purchase Common Stock of the Company. The documents governing the terms of such warrants contain a provision prohibiting Lincoln and SPE, as applicable, from exercising warrants for shares of Common Stock if doing so would result in the Reporting Person and their affiliates beneficially owning shares of Common Stock that represent more than 9.99% of the outstanding shares of Common Stock as determined under Section 13(d) of the Securities Exchange Act of 1934. This number assumes that Lincoln and SPE may be deemed to be affiliated and under common control.
(7) Includes 3,660,000 shares issuable upon exercise of outstanding stock options exercisable within 60 days of February 28, 2006.

2

© 1995-2006 EDGAR Online, Inc. All rights reserved.
Terms of Use | Privacy Statement

Dec 22, 2006 07:21AM

Dec 22, 2006 07:51AM

Dec 22, 2006 08:17AM

Dec 22, 2006 09:37AM

Dec 22, 2006 09:40AM

Dec 22, 2006 09:51AM

Dec 22, 2006 11:11AM

Dec 22, 2006 11:38AM

Dec 22, 2006 02:02PM

Dec 22, 2006 04:16PM

Dec 22, 2006 07:45PM

Dec 23, 2006 04:45AM
Share
New Message
Please login to post a reply